NCT01079858View on ClinicalTrials.gov

Evaluation of FID 114657 in Dry Eye Subjects

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2010

Conditions
Meibomian Gland Dysfunction
Interventions
OTHER

FID 114657 (ORB Preserved Ocular Emulsion)

Patients will dose as needed throughout the day (PRN) for 4 weeks.

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY